Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China
· Delayed Price · Currency is CNY 16.91
+0.31 (1.87%)
Apr 25, 2025, 10:45 AM CST
SHE:300233 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 3,353 | 3,521 | 3,484 | 3,127 | 2,949 | Upgrade
|
| Other Revenue | 20.18 | 17.66 | 21.46 | 11.78 | 12.55 | Upgrade
|
| Revenue | 3,373 | 3,538 | 3,506 | 3,138 | 2,962 | Upgrade
|
| Revenue Growth (YoY) | -4.66% | 0.93% | 11.70% | 5.96% | 5.98% | Upgrade
|
| Cost of Revenue | 2,070 | 2,073 | 1,932 | 1,542 | 1,275 | Upgrade
|
| Gross Profit | 1,304 | 1,465 | 1,574 | 1,597 | 1,687 | Upgrade
|
| Selling, General & Admin | 842.74 | 1,035 | 996.39 | 1,168 | 1,113 | Upgrade
|
| Research & Development | 170.34 | 184.71 | 171.1 | 178.34 | 191.91 | Upgrade
|
| Other Operating Expenses | 27.81 | 22.5 | 32.79 | 30.74 | 10.32 | Upgrade
|
| Operating Expenses | 1,038 | 1,245 | 1,200 | 1,373 | 1,334 | Upgrade
|
| Operating Income | 265.27 | 219.96 | 373.34 | 223.97 | 352.62 | Upgrade
|
| Interest Expense | -18.48 | -24.92 | -26.82 | -27.04 | -23.31 | Upgrade
|
| Interest & Investment Income | 12.9 | 15.18 | 15.7 | 24.54 | 12.42 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.58 | 1.34 | 0.97 | -10.1 | -16.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.2 | -3.32 | -2.52 | -4.49 | -7.04 | Upgrade
|
| EBT Excluding Unusual Items | 265.08 | 208.23 | 360.66 | 206.89 | 318.67 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -741.73 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.58 | -0.08 | -12.6 | -1.13 | 1.72 | Upgrade
|
| Gain (Loss) on Sale of Assets | 3.37 | -1.98 | 1.53 | 1.18 | 0.85 | Upgrade
|
| Asset Writedown | -16.45 | -2.66 | -21.32 | -39.23 | -4.88 | Upgrade
|
| Other Unusual Items | 18.02 | 21.9 | 17.7 | 28.84 | - | Upgrade
|
| Pretax Income | 268.45 | 225.41 | 345.97 | 196.55 | -425.38 | Upgrade
|
| Income Tax Expense | 60.71 | 32.1 | 60.09 | 73.47 | 55.3 | Upgrade
|
| Earnings From Continuing Operations | 207.74 | 193.31 | 285.88 | 123.08 | -480.68 | Upgrade
|
| Minority Interest in Earnings | -10.95 | -18.6 | -12.51 | -15.1 | -8.17 | Upgrade
|
| Net Income | 196.78 | 174.71 | 273.37 | 107.98 | -488.84 | Upgrade
|
| Net Income to Common | 196.78 | 174.71 | 273.37 | 107.98 | -488.84 | Upgrade
|
| Net Income Growth | 12.63% | -36.09% | 153.15% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 378 | 388 | 385 | 386 | 388 | Upgrade
|
| Shares Outstanding (Diluted) | 378 | 388 | 385 | 386 | 388 | Upgrade
|
| Shares Change (YoY) | -2.53% | 0.84% | -0.17% | -0.60% | -0.76% | Upgrade
|
| EPS (Basic) | 0.52 | 0.45 | 0.71 | 0.28 | -1.26 | Upgrade
|
| EPS (Diluted) | 0.52 | 0.45 | 0.71 | 0.28 | -1.26 | Upgrade
|
| EPS Growth | 15.56% | -36.62% | 153.57% | - | - | Upgrade
|
| Free Cash Flow | 153.97 | 321.18 | -118.04 | 61.04 | 273.69 | Upgrade
|
| Free Cash Flow Per Share | 0.41 | 0.83 | -0.31 | 0.16 | 0.70 | Upgrade
|
| Dividend Per Share | 0.250 | 0.200 | 0.150 | 0.198 | 0.202 | Upgrade
|
| Dividend Growth | 25.00% | 33.33% | -24.31% | -1.82% | 0.92% | Upgrade
|
| Gross Margin | 38.65% | 41.40% | 44.89% | 50.87% | 56.95% | Upgrade
|
| Operating Margin | 7.86% | 6.22% | 10.65% | 7.14% | 11.91% | Upgrade
|
| Profit Margin | 5.83% | 4.94% | 7.80% | 3.44% | -16.50% | Upgrade
|
| Free Cash Flow Margin | 4.56% | 9.08% | -3.37% | 1.94% | 9.24% | Upgrade
|
| EBITDA | 582.11 | 525.43 | 624.67 | 443.16 | 550.66 | Upgrade
|
| EBITDA Margin | 17.26% | 14.85% | 17.82% | 14.12% | 18.59% | Upgrade
|
| D&A For EBITDA | 316.84 | 305.48 | 251.33 | 219.18 | 198.05 | Upgrade
|
| EBIT | 265.27 | 219.96 | 373.34 | 223.97 | 352.62 | Upgrade
|
| EBIT Margin | 7.86% | 6.22% | 10.65% | 7.14% | 11.91% | Upgrade
|
| Effective Tax Rate | 22.62% | 14.24% | 17.37% | 37.38% | - | Upgrade
|
| Revenue as Reported | 3,373 | 3,538 | 3,506 | 3,138 | 2,962 | Upgrade
|
| Advertising Expenses | 136.97 | 173.31 | 198.82 | - | - | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.